⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2121960 | 1.00 | — | — | |
| SCHEMBL514925 | 0.85 | — | — | |
| SCHEMBL9244206 | 0.84 | — | — | |
| SCHEMBL2175547 | 0.81 | — | — | |
| SCHEMBL10752548 | 0.81 | — | — | |
| SCHEMBL4368969 | 0.78 | — | — | |
| SCHEMBL9421347 | 0.76 | — | — | |
| SCHEMBL12970939 | 0.74 | — | — | |
| SCHEMBL9244219 | 0.73 | — | — | |
| SCHEMBL11674955 | 0.68 | KDM4E (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388876-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH SILICON CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| EP-2443486-B1 | BIOMEDICAL DEVICES | BAUSCH & LOMB (US) | 2017-03-01 | — | — | EP | claimed |
| EP-2443486-A2 | BIOMEDICAL DEVICES | Bausch & Lomb Incorporated (US) | 2012-04-25 | — | — | EP | claimed |
| US-8133960-B2 | Biomedical devices | BAUSCH & LOMB INCORPORATED (US) | 2012-03-13 | — | — | US | claimed |
| EP-2356497-A2 | SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS | Novartis AG (CH) | 2011-08-17 | — | — | EP | claimed |
| WO-2010147875-A2 | BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2010-12-23 | — | — | WO | claimed |
| US-20100318185-A1 | Biomedical Devices | BAUSCH & LOMB INCORPORATED (US) | 2010-12-16 | — | — | US | claimed |
| US-20100317817-A1 | Biomedical devices | BAUSCH & LOMB INCORPORATED (US) | 2010-12-16 | — | — | US | claimed |
| WO-2010056687-A2 | SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS | NOVARTIS AG (CH) | 2010-05-20 | — | — | WO | claimed |
| EP-2091979-A2 | ACTINICALLY CURABLE SILICONE HYDROGEL COPOLYMERS AND USES THEREOF | Novartis AG (CH) | 2009-08-26 | — | — | EP | claimed |
| WO-2008076736-A2 | ACTINICALLY CURABLE SILICONE HYDROGEL COPOLYMERS AND USES THEREOF | NOVARTIS AG (CH) | 2008-06-26 | — | — | WO | claimed |
| US-11398641-B2 | Silicon-based energy storage devices with silicon containing electrolyte additives | ENEVATE CORPORATION (US) | 2022-07-26 | — | — | US | disclosed |
| US-20200388876-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH SILICON CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| EP-3554811-A1 | METHOD FOR PRODUCING CONTACT LENSES | Novartis AG (CH) | 2019-10-23 | — | — | EP | disclosed |
| WO-2018152392-A1 | IONICALLY MODIFIED SILICONES, COMPOSITIONS, AND MEDICAL DEVICES FORMED THEREFROM | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-08-23 | — | — | WO | disclosed |
| EP-2094235-A2 | OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF | Novartis AG (CH) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008116131-A2 | PREPOLYMERS WITH DANGLING POLYSILOXANE-CONTAINING POLYMER CHAINS | NOVARTIS AG (CH) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008073193-A2 | OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF | NOVARTIS AG (CH) | 2008-06-19 | — | — | WO | disclosed |
| EP-0387706-A2 | Oxygen permeable hard contact lens | KURARAY CO., LTD. (JP) | 1990-09-19 | — | — | EP | disclosed |
| US-4711943-A | IMPROVED OXYGEN PERMEABILITY AND STABILITY | SOLA U.S.A. INC. (US) | 1987-12-08 | — | — | US | disclosed |